SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

🇨🇦 Laotian Times (CA) —
SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

AI Summary

SynbioTech has launched SYNMUE™, a clinically validated probiotic targeting immune aging, demonstrated to increase natural killer cell levels by up to 48%. The product will be showcased at the Probiota Americas 2026 event in Vancouver.

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 6, 2026 /PRNewswire/ — Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUE™, a clinically validated probiotic featuring Lactiplantibacillus plantarum LP28, designed to target immune aging, also known as immunosenescence. The […]

Markets Deals Health AI & Tech SynbioTech SYNMUE probiotic immunosenescence natural killer cells clinical study Probiota Americas Vancouver

Read original source →